Recent Advances with Liposomes as Drug Carriers - Advanced Biomaterials and Biodevices - page 110

142. Rivest, V., et al. , Novel liposomal formulation for targeted gene delivery.
Pharm Res , 2007. 24(5): p. 981-90.
143. van der Meel, R., et al. , Tumor-targeted Nanobullets: Anti-EGFR nanobody-
liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment. J
Control Release , 2012. 159(2): p. 281-9.
144. Shmeeda, H., et al. , Her2-targeted pegylated liposomal doxorubicin: reten-
tion of target-specii c binding and cytotoxicity at er in vivo passage. J Control
Release , 2009. 136(2): p. 155-60.
145. Di Paolo, D., et al. , Neuroblastoma-targeted nanoparticles entrapping siRNA
specii cally knockdown ALK. Mol h er , 2011. 19(6): p. 1131-40.
146. Scott,R.C., et al. , Targeted delivery of antibody conjugated liposomal drug car-
riers to rat myocardial infarction. Biotechnol Bioeng , 2007. 96(4): p. 795-802.
147. Cheng, W.W., et al. , Expression and purii cation of two anti-CD19 single
chain Fv fragments for targeting of liposomes to CD19-expressing cells.
Biochem Biophys Acta , 2007. 1768(1): p. 21-9.
148. Hussain, S., et al. , Antitumor activity of an epithelial cell adhesion molecule
targeted nanovesicular drug delivery system. Mol Cancer h er , 2007. 6(11):
p. 3019-27.
149. Roth, A., et al. , Anti-CD166 single chain antibody-mediated intracellular
delivery of liposomal drugs to prostate cancer cells. Mol Cancer h er , 2007.
6(10): p. 2737-46.
150. Sudimack, J. and R.J. Lee, Targeted drug delivery via the folate receptor. Adv
Drug Deliv Rev , 2000. 41(2): p. 147-62.
151. Yang, K.K., et al. , Folate-modii ed-chitosan-coated liposomes for tumor-tar-
geted drug delivery. Journal of Materials Science , 2012. 48(4): p. 1717-1728.
152. Zhang, Z. and J. Yao, Preparation of irinotecan-loaded folate-targeted
liposome for tumor targeting delivery and its antitumor activity. AAPS
PharmSciTech , 2012. 13(3): p. 802-10.
153. Gabizon, A., et al. , Improved therapeutic activity of folate-targeted liposomal
doxorubicin in folate receptor-expressing tumor models. Cancer Chemother
Pharmacol , 2010. 66(1): p. 43-52.
154. Yamada, A., et al. , Design of folate-linked liposomal doxorubicin to its anti-
tumor ef ect in mice. Clin Cancer Res , 2008. 14(24): p. 8161-8.
155. Shmeeda, H., et al. , Delivery of zoledronic acid encapsulated in folate-tar-
geted liposome results in potent in vitro cytotoxic activity on tumor cells. J
Control Release , 2010. 146(1): p. 76-83.
156. Shmeeda, H., et al. , Liposome encapsulation of zoledronic acid results in
major changes in tissue distribution and increase in toxicity. J Control
Release , 2013. 167(3): p. 265-75.
157. Moret, F., D. Scheglmann, and E. Reddi, Folate-targeted PEGylated lipo-
somes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)chlo-
rin (m-THPC). Photochem Photobiol Sci , 2013. 12(5): p. 823-34.
158. Lu, Y., et al. , Role of formulation composition in folate receptor-targeted
liposomal doxorubicin delivery to acute myelogenous leukemia cells. Mol
Pharm , 2007. 4(5): p. 707-12.